Inactive Instrument

News Actelion

Stocks

ATLN

CH0010532478

Biotechnology & Medical Research

All News

20-04-06	Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents	AQ
17-10-31	Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017	GL
17-07-31	Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake	RE
17-06-30	Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung	GL
17-06-16	Actelion : Johnson & Johnson Completes Acquisition of Actelion	GL
17-06-15	Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	PU
17-06-14	Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson	GL
17-06-09	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
17-06-09	Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16	RE
17-06-09	Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16	RE
17-06-09	Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange	GL
17-06-09	Actelion : Johnson & Johnson announces expected settlement of Actelion tender offer on June 16, 2017	GL
17-06-08	Actelion : provides an update on the Phase III IMPACT program with cadazolid in CDAD	GL
17-05-22	Actelion : provides an update on the progress towards launching Idorsia - Key results for pipeline assets to be developed by Idorsia	GL
17-05-18	Actelion : Johnson & Johnson offers EU concessions over Actelion deal	RE
17-05-15	Actelion : announces changes to its executive team upon completion of the transaction with Johnson & Johnson	GL
17-04-27	Actelion : Publication of the definitive notice of the end result of Actelion tender offer	GL
17-04-24	Actelion : Publication of the provisional notice of the end result of Actelion tender offer	GL
17-04-20	Actelion : Johnson & Johnson target Actelion could exit Swiss benchmark SMI index this month	RE
17-04-18	Actelion : Johnson & Johnson first quarter revenue misses estimates; new forecast includes Actelion	RE
17-04-10	Actelion : amends its financial reporting schedule	GL
17-04-05	Actelion : shareholders back R&D spinoff, keep J&J deal on track	RE
17-04-05	Actelion : Annual General Meeting of Shareholders 2017	GL
17-03-31	Actelion : J&J declares Actelion tender offer a success, sees closing in second quarter	RE
17-03-31	Actelion : Johnson & Johnson publishes interim result for Actelion tender offer and declares the tender offer successful	GL